CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Por um escritor misterioso

Last updated 20 setembro 2024

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus

Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells

Frontiers Depletion and Dysfunction of Dendritic Cells: Understanding SARS -CoV-2 Infection

Smoking and SARS-CoV-2 Impair Dendritic Cells and Regulate DC-SIGN Expression in Tissues

Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors - ScienceDirect

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

IJMS, Free Full-Text

PDF) CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Mechanisms of SARS-CoV-2 entry into cells

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight

Recomendado para você